IPQ Inside the global regulatory dialogue

More Clarity Sought in FDA’s Inactive Ingredient Database Regarding Drug Delivery Devices

Sep 27th, 2016

Please Log in to print the full article

CDER Weighs in on Transdermal Patches Zuk began her discussion of the emerging dosage form challenges by focusing on transdermal patches, which are listed in the IID with the maximum potency as milligrams per patch....

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2021 IPQ Publications